Pharma Sector

Canva : Key sectors likely to benefit from India-US trade deal

Tariff Relief Sparks Rally In Export-Oriented Sectors As India–US Trade Deal Eases Uncertainty

Gemini AI : Pharma sector has remained relatively stable and continued to outperform benchmark Nifty 50. (AI-generated)

Nifty Pharma Extends Winning Streak For 5th Straight Session Even As Trump Tariffs Trample D-Street

Gemini AI, Instagram/@whitehouse : Despite Trump’s harsh tone, the Nifty Pharma index surged by as much as 0.46 per cent during the session. (AI-generated)

Pharma Stocks Gain Despite Trump's 200% Tariff Threat - Here's Why

Image Created Using AI : Alembic Pharma Shares Surge After US FDA Nod For Ovarian Cancer Drug

Alembic Pharma Shares Surge After US FDA Nod For Ovarian Cancer Drug

BY Outlook Money

Canva : The Nifty Pharma index has been consolidating in a tight range of 20,500–22,300 since April this year

Nifty Pharma Struggles To Scale New High, Remains Range-Bound Since April: Reasons Behind Stagnation

Canva : The Nifty Pharma gained 1.25 per cent in todays session.

Pharma Stocks Gain Up To 5.50 Per Cent As US Outlines Plan To Lower Drug Prices

BY Outlook Money

Pharma Stocks Slide On Trump Tariff Fears; Nifty Pharma Index Drops

Pharma Stocks Slide On Trump Tariff Fears; Nifty Pharma Index Drops

BY Outlook Money

Canva : Trump said the tariffs will incentivise drug-makers to shift their operations to the US

Pharma Stocks Tumble After Trump Reiterates ‘Major’ Tariff Threats

BY Outlook Money

The Nifty Pharma index is currently trading 13.40 per cent below its all-time high level

Nifty Pharma Emerges As Top Sectoral Gainer, Led By Dr Reddy’s, Cipla

BY Outlook Money

Sun Pharmas share price has risen over 5 per cent in the last 5 trading sessions.

Sun Pharmaceutical Share Price Climbs 3 Per Cent: Here’s Why

BY Outlook Money

Nifty Pharma closes in red amid the US President Donald Trumps announcement of 25 per cent tariff on pharma import.

Nifty Pharma In Red, Dr Reddy, Lupin, Aurobindo, Sun Pharma Down Up To 3 Per Cent; Here’s Why

BY Outlook Money

Why Sunil Singhania Likes Banking, IT, And Pharma Sectors?

Why Sunil Singhania Likes Banking, IT, And Pharma Sectors?

BY Outlook Money